Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ford Motor Company (F) vs Eli Lilly And Co (LLY) Price & Performance

Ford Motor CompanyTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Ford Motor Company vs Eli Lilly And Co — how do they compare? Ford Motor Company trades at $14.15 (market cap $56.50B), while Eli Lilly And Co trades at $1,183.49 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 18.2× Ford Motor Company's market cap, and Ford Motor Company pays the higher dividend (4.23%). Which is the better fit depends on your goals.

FLLY
Market Cap
$56.50B$1.03T
Sector
Consumer CyclicalHealth
52-Week High
$17.44$1.24K
52-Week Low
$10.82$625.65
Enterprise Value
$185.53B$1.07T
Dividend Yield
4.23%0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ford Motor Company

Ford (F) trades at $13.93, up 0.44% on the day, with a neutral technical outlook and mixed fundamental signals. The company reported a net loss of $8.18 billion in 2025 despite revenue growth to $187.27 billion, reflecting margin pressure. Recent news highlights labor agreements, EV initiatives, and a 4%+ dividend yield. Analyst consensus is a $15.00 price target with a Hold-heavy rating distribution.

The stock presents a value opportunity with low P/E and P/S ratios, but significant risks include persistent net losses, high debt levels, and competitive pressures in the EV transition. Upside depends on execution of cost controls and successful new product launches, particularly in electric vehicles.

Eli Lilly And Co

LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.

Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ford Motor Company

Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.

Read more on F

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY